drugset / Trial / NCT00140933

A Study to Evaluate Rofecoxib Versus Placebo and Diclofenac in Patients With Acute Painful Rotator Cuff Syndrome

NCT00140933 ↗

Phase 3 Terminated 274 enrolled Merck Sharp & Dohme LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

Comparing the short-term efficacy of rofecoxib versus placebo. Patients receive rofecoxib or placebo or diclofenac and fill out a patient diary on daytime pain severity during daily activities, night pain severity, and acetaminophen/paracetamol intake.

Timeline

Start
2003-04
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Diclofenac Other / unclassified — —
Subject rofecoxib Small molecule — —

Indications

No indication recorded.